Fraunhofer Institute of Toxicology and Experimental Medicine, Nikolai-Fuch-Str 1, 30635 Hannover, Germany.
Respir Res. 2012 Feb 1;13(1):8. doi: 10.1186/1465-9921-13-8.
Allergen-containing subpollen particles (SPP) are released from whole plant pollen upon contact with water or even high humidity. Because of their size SPP can preferentially reach the lower airways where they come into contact with surfactant protein (SP)-D. The aim of the present study was to investigate the influence of SP-D in a complex three-dimensional human epithelial airway model, which simulates the most important barrier functions of the epithelial airway. The uptake of SPP as well as the secretion of pro-inflammatory cytokines was investigated.
SPP were isolated from timothy grass and subsequently fluorescently labeled. A human epithelial airway model was built by using human Type II-pneumocyte like cells (A549 cells), human monocyte derived macrophages as well as human monocyte derived dendritic cells. The epithelial cell model was incubated with SPP in the presence and absence of surfactant protein D. Particle uptake was evaluated by confocal microscopy and advanced computer-controlled analysis. Finally, human primary CD4+ T-Cells were added to the epithelial airway model and soluble mediators were measured by enzyme linked immunosorbent assay or bead array.
SPP were taken up by epithelial cells, macrophages, and dendritic cells. This uptake coincided with secretion of pro-inflammatory cytokines and chemokines. SP-D modulated the uptake of SPP in a cell type specific way (e.g. increased number of macrophages and epithelial cells, which participated in allergen particle uptake) and led to a decreased secretion of pro-inflammatory cytokines.
These results display a possible mechanism of how SP-D can modulate the inflammatory response to inhaled allergen.
接触水甚至高湿度时,完整花粉中的含过敏原亚花粉颗粒(SPP)会释放出来。由于其粒径较小,SPP 可优先到达下呼吸道,与表面活性剂蛋白(SP)-D 接触。本研究旨在研究 SP-D 在复杂的三维人上皮气道模型中的影响,该模型模拟了上皮气道最重要的屏障功能。研究了 SPP 的摄取以及促炎细胞因子的分泌。
从梯牧草中分离 SPP,然后进行荧光标记。使用人Ⅱ型肺泡细胞样细胞(A549 细胞)、人单核细胞衍生的巨噬细胞和人单核细胞衍生的树突状细胞构建人上皮气道模型。在存在和不存在表面活性剂蛋白 D 的情况下,将上皮细胞模型与 SPP 孵育。通过共聚焦显微镜和先进的计算机控制分析评估颗粒摄取。最后,将人原代 CD4+T 细胞添加到上皮气道模型中,并通过酶联免疫吸附测定或珠阵列测量可溶性介质。
SPP 被上皮细胞、巨噬细胞和树突状细胞摄取。这种摄取与促炎细胞因子和趋化因子的分泌一致。SP-D 以细胞类型特异性的方式调节 SPP 的摄取(例如,增加参与过敏原颗粒摄取的巨噬细胞和上皮细胞的数量),并导致促炎细胞因子分泌减少。
这些结果显示了 SP-D 如何调节吸入过敏原引起的炎症反应的可能机制。